3 insiders reported 5 Form 4 transactions for Astria Therapeutics, Inc. (ATXS) over the past 18 months (most recent 2026-01-23). Recent activity: Komjathy Andrew (Chief Commercial Officer) Sell 45 shares, Violin Jonathan (Director) Sell 263,321 shares, Komjathy Andrew (Chief Commercial Officer) Sell 10 shares, Milne Jill C. (CEO and President) Sell 4,377 shares, Komjathy Andrew (Chief Commercial Officer) Sell 45 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-23 | Komjathy Andrew | Chief Commercial Officer | Sell | 45 | $0 |
| 2026-01-23 | Violin Jonathan | Director | Sell | 263,321 | $0 |
| 2026-01-23 | Komjathy Andrew | Chief Commercial Officer | Sell | 10 | $0 |
| 2026-01-23 | Milne Jill C. | CEO and President | Sell | 4,377 | $0 |
| 2026-01-23 | Komjathy Andrew | Chief Commercial Officer | Sell | 45 | $0 |
Source: SEC Form 4 filings · as of 2026-01-23